Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer.
Wang L, Tang W, Yang S, He P, Wang J, Gaedcke J, Ströbel P, Azizian A, Ried T, Gaida MM, Yfantis HG, Lee DH, Lal A, Van den Eynde BJ, Alexander HR, Ghadimi BM, Hanna N, Hussain SP. Wang L, et al. Among authors: hanna n. Int J Cancer. 2020 Jun 1;146(11):3160-3169. doi: 10.1002/ijc.32733. Epub 2019 Nov 19. Int J Cancer. 2020. PMID: 31609478 Free PMC article.
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP. Zhang G, et al. Among authors: hanna n. Clin Cancer Res. 2013 Sep 15;19(18):4983-93. doi: 10.1158/1078-0432.CCR-13-0209. Epub 2013 Aug 5. Clin Cancer Res. 2013. PMID: 23918603 Free PMC article.
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S, He P, Wang J, Schetter A, Tang W, Funamizu N, Yanaga K, Uwagawa T, Satoskar AR, Gaedcke J, Bernhardt M, Ghadimi BM, Gaida MM, Bergmann F, Werner J, Ried T, Hanna N, Alexander HR, Hussain SP. Yang S, et al. Among authors: hanna n. Cancer Res. 2016 Jul 1;76(13):3838-50. doi: 10.1158/0008-5472.CAN-15-2841. Epub 2016 Apr 20. Cancer Res. 2016. PMID: 27197190 Free PMC article.
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Wang J, He P, Gaida M, Yang S, Schetter AJ, Gaedcke J, Ghadimi BM, Ried T, Yfantis H, Lee D, Weiss JM, Stauffer J, Hanna N, Alexander HR, Hussain SP. Wang J, et al. Among authors: hanna n. Oncotarget. 2016 Aug 16;7(33):52993-53004. doi: 10.18632/oncotarget.10323. Oncotarget. 2016. PMID: 27367029 Free PMC article.
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer.
Wang J, Yang S, He P, Schetter AJ, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Gaida MM, Hanna N, Alexander HR, Hussain SP. Wang J, et al. Among authors: hanna n. Clin Cancer Res. 2016 Dec 15;22(24):5992-6001. doi: 10.1158/1078-0432.CCR-16-0511. Epub 2016 Jul 8. Clin Cancer Res. 2016. PMID: 27401251 Free PMC article.
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T, Yfantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back TC, Yanaga K, Hanna N, Alexander HR, Maitra A, Hussain SP. Funamizu N, et al. Among authors: hanna n. Int J Cancer. 2013 Feb 15;132(4):785-94. doi: 10.1002/ijc.27736. Int J Cancer. 2013. PMID: 22821831 Free PMC article.
800 results